Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome

Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome

US Patent 12121514 · Granted Oct 22, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the diagnosis and treatment of lymphatic system dis2025
Compositions and methods for the diagnosis and treatment of lymphatic system dis2025
Compositions and methods for the diagnosis and treatment of lymphatic system dis2025
Association of genetic variations to diagnose and treat attention-deficit hypera2024
Compositions and methods targeting the Th2 pathway for the treatment of asthma2024
Methods of diagnosing and treating conduct disorder2023
Methods of diagnosing and treating conduct disorder2023
Methods of diagnosing and treating anxiety disorder2023
Nonselective metabotropic glutamate receptor activators for treatment of anorexi2023
Methods for use in the diagnosis of autoimmune diseases2023
Methods of diagnosing and treating ADHD in biomarker positive subjects2023
Association of genetic variations to diagnose and treat attention-deficit hypera2023